Acumen Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ABOS Nasdaq 8731 https://acumenpharm.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Acumen Pharmaceuticals Inc

Is Novo Nordisk (NVO) Stock Outpacing Its Medical Peers This Year? - Jan 6th, 2023 2:40 pm
Acumen Pharmaceuticals Appoints Derrell Porter, M.D., to its Board of Directors - Jan 4th, 2023 1:00 pm
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Q3 2022 Earnings Call Transcript - Dec 29th, 2022 11:02 am
Acumen Pharmaceuticals Reports Third Quarter 2022 Financial Results and Business Highlights - Nov 14th, 2022 9:01 pm
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference - Nov 9th, 2022 9:01 pm
Acumen Pharmaceuticals to Report Third Quarter 2022 Financial Results on Nov. 14, 2022 - Nov 7th, 2022 9:01 pm
Acumen Publishes Phase 1 Trial Design and Clinical Development Plan for ACU193, an Anti-Amyloid Beta Oligomer Antibody for Alzheimer’s Disease - Nov 1st, 2022 12:00 pm
Acumen’s ACU193, an Anti-Amyloid Beta Oligomer Antibody, Granted FDA Fast Track Designation for Alzheimer's Disease - Oct 24th, 2022 12:00 pm
We Think Acumen Pharmaceuticals (NASDAQ:ABOS) Can Afford To Drive Business Growth - Sep 8th, 2022 4:44 pm
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2022 Earnings Call Transcript - Aug 16th, 2022 3:00 am
Acumen Pharmaceuticals Reports Financial Results for Second Quarter 2022 and Business Highlights - Aug 15th, 2022 8:05 pm
Acumen Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 15, 2022 - Aug 8th, 2022 8:15 pm
Acumen presents poster describing method to standardize amyloid beta oligomer assays supporting therapeutic development for early Alzheimer’s disease - Aug 1st, 2022 2:30 pm
Acumen Pharmaceuticals to Participate in Upcoming Investor and Scientific Conferences - Jul 26th, 2022 8:15 pm
Hopeful week for insiders who might be regretting buying US$5.7m of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) stock earlier this year - Jun 8th, 2022 12:00 pm
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2022 Earnings Call Transcript - May 17th, 2022 2:00 am
Acumen Pharmaceuticals Reports Financial Results for First Quarter 2022 and Business Highlights - May 16th, 2022 8:05 pm
Acumen Pharmaceuticals to Report First Quarter 2022 Financial Results on May 16, 2022 - May 11th, 2022 9:08 pm
Comprehensive Analysis in Frontiers in Neuroscience Highlights Acumen Pharmaceuticals’ New Approach to Treating Alzheimer's Disease - Apr 27th, 2022 12:00 pm
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2021 Earnings Call Transcript - Apr 2nd, 2022 4:00 am